Assisted Reproductive Technology (ART) Market – By Type (Product, Procedure Type [Fresh Donor, Fresh Non-donor, Frozen Donor, Frozen Non-donor], Technology [IVF, Artificial Insemination]), End-User (Hospital, Fertility Clinic) – Global Forecast (2024 – 2032)

Assisted Reproductive Technology Market Size

Assisted Reproductive Technology Market size was valued at around USD 34.7 billion in 2023 and is estimated to grow at 6.9% CAGR from 2024 to 2032. Assisted reproductive technology refers to a medical treatment procedure that addresses infertility problems. It includes in-vitro fertilization and artificial insemination. Increasing success rates of these procedures has offered more effective care solutions in hospitals, fertility clinics and surgical centers.
 

The rising prevalence of infertility across the population base serves as a significant driver for the ART market. According to the World Health Organization (WHO), in 2023, around 17.5% of the adult population – roughly 1 in 6 worldwide experience infertility, showing the urgent need to increase access to affordable, high-quality fertility care for those in need. Further, as per the same report, lifetime infertility prevalence was 17.8% for high-income countries and 16.5% for low- and middle-income countries. As fertility rates decline globally, individuals and couples are increasingly turning to ART services to overcome infertility challenges and achieve their family-building goals.
 

Furthermore, increasing shift towards infertility treatment devices, rising adoption of infertility drugs, advancement in mother care products, rising healthcare expenditure globally, government initiatives and funding, and increasing education & awareness, are the increasing factors nurturing the growth of the market.
 

Assisted Reproductive Technology Market Trends

With the evolution of societal attitudes and the growing acceptance of ART, there is a rising trend among individuals and couples to utilize these advanced reproductive technologies to surmount infertility challenges and achieve their aspirations of parenthood.
 

• Over time, societal norms and values regarding family formation, parenthood, and reproductive options have evolved. There is greater acceptance and recognition of diverse family structures, including single-parent families, same-sex couples, and individuals pursuing parenthood independently.
   
• For instance, according to the Department of Health, State Government of Victoria, Australia, in 2024, single-male-parent families are the fastest growing family, increasing between 44% to 65% by 2041. As per the same report, single-female-parent families are projected to make up 13% to 14% of all families in 2041.
   
• Further as per the recent statistics, in the 1950s, less than 10% of families with children were single parent, whereas in 2022, among families with children, 31% were single-parent — more than three times as common.
   
• Increased cultural and religious acceptance of ART, coupled with a desire to adhere to cultural and religious values while addressing infertility, and utilizing fertility testing devices, leading to greater utilization of ART services among diverse populations, thereby stimulating the growth of the market.
   

ART Market Analysis

Based on type, the market is bifurcated into product and procedure. The procedure segment is estimated to account for USD 58.6 billion by 2032.
 

• The prevalence of infertility is increasing globally due to various factors such as lifestyle changes, environmental factors, and delaying childbirth. As a result, more individuals and couples are seeking fertility treatments, fertility supplements, and adopting ART procedures, to achieve their goal of parenthood.
   
• It encompasses various assisted reproductive technology (ART) procedures such as in vitro fertilization (IVF) and artificial insemination. Increasing number of in-vitro fertilization increases the adoption rate of assisted reproductive technology.
   
• For instance, according to the Japan Society of Obstetrics and Gynecology, in 2021, the number of children born through in vitro fertilization as part of infertility treatment increased by 9,416 from the previous year to a record high of 69,797 in Japan. Furthermore, the most common age for those receiving treatment was 39, with 39,631 cases, followed by those aged 40 and 41.
   
• Continuous advancements in ART technologies and techniques have significantly improved success rates and outcomes of procedures. Innovations such as time-lapse imaging, preimplantation genetic testing, and embryo vitrification have enhanced the efficacy and safety of ART procedures, leading to increased adoption and demand.
   

Based on end-user/provider, the assisted reproductive technology market is divided into hospitals, fertility clinics, and other end-users/providers. The fertility clinics segment accounted for USD 18.8 billion in 2023.
 

• These clinics are dedicated to reproductive medicine and have specialized expertise in diagnosing and treating infertility. They employ reproductive endocrinologists, fertility specialists, embryologists, and other healthcare professionals who are trained and experienced in ART procedures.
   
• Increase in fertility clinics is a significant driver for the market leading to increased uptake of ART among the patients.
   
• According to the National Institutes of Health, in 2023, India is witnessing a surge in IVF clinics and chains, with an estimated 2500 clinics functional across India.
   
• Further, according to the National Library of Medicine, in 2021, a total of 601 fertility clinics in Japan performed treatments of assisted reproductive technology (ART). Thus, such aforementioned factors are expected to augment the segmental growth.
   

U.S. assisted reproductive technology market is anticipated to grow at CAGR of 6.5% during the analysis timeframe.
 

• Increasing percentage of IVF delivery rate/cycle in the US further attracts a major pool of patients to adopt the ART procedures, thereby escalating the growth of the market.
   
• According to the Centers for Disease Control and Prevention, in 2021, 86,146 infants born (or 2.3% of all infants born in the U.S.) were conceived through the use of ART in the U.S. IVF enables individuals who use fertility preservation services to save their eggs, sperm, or reproductive tissues to have children at a later time.
   

Germany assisted reproductive technology (ART) market is anticipated to witness lucrative growth between 2024 – 2032.
 

• The country has witnessed a growing demand for ART services due to factors such as delayed childbearing, rising infertility rates, and increased awareness about assisted reproductive technologies.
   
• The trend of postponing parenting for career goals and financial stability has led to an increased reliance on ART services in the country.
   

Japan assisted reproductive technology market is expected to grow significantly over the years.
 

• Japan is known for its technological innovation across various industries, including healthcare. Japanese companies have developed advanced ART technologies and equipment, making them a preferred choice for patients seeking fertility treatments.
   
• Similar to many developed countries, Japan has an aging population and declining birth rates. This demographic trend has led to an increase in demand for ART services among couples facing infertility issues or delaying parenthood.
   

South Africa ART market is anticipated to witness lucrative growth between 2024 – 2032.
 

• South Africa government has implemented regulations to govern the practice of ART and ensure the safety and quality of fertility treatments. Additionally, the government provides support in terms of infrastructure development and funding for research and development in the field of reproductive medicine.
   

Assisted Reproductive Technology Market Share

The assisted reproductive technology industry is highly competitive, marked by several players striving for market dominance. Providers offer comprehensive products and procedures with improved efficiency and affordability. This includes advancements in catheters, needles, media, incubators, and vitrification devices. Competition is driven by factors such as the quality, reliability, performance, cost, and compliance with regulatory standards. Strategic partnerships with companies and healthcare networks play a crucial role in market positioning.
 

Assisted Reproductive Technology Market Companies

Some of the eminent market participants operating in the assisted reproductive technology industry (ART) include:

• Esco Micro Pte. Ltd
• Gynotec
• Hamilton Thorne Ltd.
• Indira IVF Hospital Private Limited
• Ivy Fertility
• Kitazato Corporation
• Laboratoire CCD
• Liverpool Partners Group
• Merck KGaA
• MISTRAL FERTILITY CLINICS S.L.
• NidaCon International AB
• Sumitomo Mitsui Financial Group, Inc.
• The Cooper Companies, Inc.
• Thermo Fisher Scientific Inc.
• Vitrolife Group
• Western Fertility Institute
   

Assisted Reproductive Technology Industry News:

• In January 2024, Ivy Fertility partnered with fertility specialty pharmacy SMP Pharmacy Solutions to enhance the patient experience across Ivy’s 13 fertility centers through a collaborative co-branding initiative. This strategic alliance aimed to optimize services and provide patients with comprehensive support, benefiting both companies through strengthened offerings and heightened patient satisfaction.
   
• In October 2023, Hamilton Thorne Ltd. acquired Gynetics Medical Products, N.V. and Gynetics Services B.V., a manufacturer of a diverse array of innovative and high-quality In-vitro fertilization (IVF) devices in the global IVF market. This strategic acquisition significantly expanded Hamilton Thorne's product offerings, strengthening its presence and competitiveness in the IVF industry.
   

The assisted reproductive technology market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Type

• Product
  • Media
  • Catheters
  • Needles
  • Vitrification devices
  • Incubators
  • Other products
• Procedure
  • By type
    • Fresh donor
    • Fresh nondonor
    • Frozen donor
    • Frozen nondonor
  • By technology
    • In-vitro fertilization (IVF)
      • IVF with intracytoplasmic sperm injection (ICSI)
      • IVF without ICSI
    • Artificial insemination - intrauterine insemination (AI-IUI)

Market, By End-user/Provider

• Hospitals
• Fertility clinics
• Other end-users/providers
• Hospitals

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • South Africa
  • Egypt
  • Rest of Middle East and Africa